Merck Advances Pediatric Oncology with Innovative ADC Modeling Case Study Merck Advances Pediatric Oncology with Innovative ADC Modeling Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…Certara2025 年 12 月 12 日
New Approach Methodologies (NAMs): By the numbers GuideInfographic 新方法学(NAMs):数据视角 We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…Certara2025 年 12 月 10 日
QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™ Live Events QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™ Japan: 2026 年 2 月 26 日 - 1:00 - 5:00 pm | Korea: 2026 年 3 月 4 日, 星期三…Certara2025 年 12 月 9 日
Virtual triplets: The next step in personalized and ethical drug development Blog Virtual triplets: The next step in personalized and ethical drug development Learn how virtual triplets, linking PBPK, QSP, and organ-on-a-chip technologies, are transforming model-informed drug development,…Certara2025 年 12 月 9 日
Expedited Pharmacometrics Regulatory Submissions Fact Sheet Expedited Pharmacometrics Regulatory Submissions Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…Certara2025 年 12 月 8 日
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings Announcement Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.Certara2025 年 12 月 3 日
History and Evolution of Innovations in Clinical Pharmacology Publication History and Evolution of Innovations in Clinical Pharmacology This paper reviews how decades of scientific and technological advances have transformed clinical pharmacology and…Danielle Pillsbury2025 年 11 月 26 日
Modeling amyloid plaque turnover dynamics improves characterization of drug effects Publication Modeling amyloid plaque turnover dynamics improves characterization of drug effects Researchers modeled how amyloid plaques form and clear in Alzheimer’s disease, helping explain how treatments…Certara2025 年 11 月 26 日
The stepwise PIP is here to stay: From pilot flexibility to permanent EU regulation Blog The stepwise PIP is here to stay: From pilot flexibility to permanent EU regulation The stepwise Paediatric Investigation Plan (PIP) is a strategic, flexible route for drug developers navigating…Certara2025 年 11 月 26 日